Chemed Corporation (CHE) Comparison with companies in other sectors?

Chemed Corporation has a share price of 14.63M. You can analyze Chemed Corporation (CHE) competitors across different market sectors through stock heatmaps.

What are CHE's NET and operating margins?

Chemed Corporation (CHE) operating margin is around 0.16, and net profit margin is approximately 0.12 as of the latest reports.

In what way does CHE's earnings per share (EPS) trend reflect its financial momentum?

Chemed Corporation (CHE) EPS is 20.51 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Chemed Corporation is 22.90, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Chemed Corporation?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Chemed Corporation like P/E which is 22.10, P/B which is 5.77, and PEG which is 7.29. Compare them with sector averages to evaluate if the stock is priced fairly.

Chemed Corporation

CHE•NYSE

Healthcare

Medical - Care Facilities

$470.72

$7.70(1.66%)

Fundamental Analysis of Chemed Corporation (CHE)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

$20.51

P/E Ratio

22.90

ROE

0.26%

Net Margin

0.12%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$6.87B

Shares OutstandingTotal number of shares issued

$14.63M

Book Value/ShareNet worth per share

$80.82

Revenue/ShareAnnual revenue per share

$170.22

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$20.51

Net MarginNet income as percentage of revenue

12.40%

Operating MarginOperating income as percentage of revenue

15.63%

ROEReturn on shareholders' equity

26.03%

ROAReturn on total assets

17.88%

ROCEReturn on capital employed

27.08%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$21.55

Cash/ShareCash and equivalents per share

$11.89

FCF YieldFree cash flow as percentage of market cap

4.59%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

$2.00

Dividend YieldAnnual dividend as percentage of stock price

0.43%

Financial Ratios Analysis data is not available for CHEFinancial Ratios Analysis details for CHE are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for CHESector Benchmarking details for CHE are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Chemed Corporation Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Chemed Corporation. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Chemed Corporation's unique business strengths and challenges.

Key Financial Metrics for Chemed Corporation

For Chemed Corporation, essential financial indicators include EPS 20.51, PE 22.90, and ROE 0.26. These key ratios reveal insights into Chemed Corporation's profitability, valuation, and operational health. Understanding these metrics enables you to compare Chemed Corporation with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Chemed Corporation

Metrics like Net Margin 12.40% and ROA 17.88% shed light on how well Chemed Corporation is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Chemed Corporation can sustain its operations and continue growing in the future.

Valuation and Market Position of Chemed Corporation

Using ratios such as P/B Ratio 5.77 and PEG Ratio 7.29, investors can assess whether Chemed Corporation is appropriately valued based on its financials and growth potential. These figures, combined with Chemed Corporation's market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Chemed Corporation

Financial health indicators, such as Debt/Equity Ratio 0.12 and Cash Flow $21.55, provide a snapshot of Chemed Corporation's ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Chemed Corporation, is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Chemed Corporation

Investing in Chemed Corporation based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Chemed Corporation focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;